Geroprotectors statistics

Tool stats & trends

Looking to identify usage trends or leading experts?

Geroprotectors specifications


Unique identifier OMICS_13959
Name Geroprotectors
Restrictions to use None
Community driven Yes
Data access File download, Browse
User data submission Allowed
Content license CC Attribution
Maintained No



This tool is not available anymore.

Publication for Geroprotectors

Geroprotectors citations


In search for geroprotectors: in silico screening and in vitro validation of signalome level mimetics of young healthy state

PMCID: 5076455
PMID: 27677171
DOI: 10.18632/aging.101047

[…] A major goal of aging research has been to identify and develop geroprotectors that increase healthspan by delaying the onset of aging and disease, but geroprotector development has been slow and mostly limited to lifespan extension in animal models. Improved in s […]


Screening and personalizing nootropic drugs and cognitive modulator regimens in silico

Front Syst Neurosci
PMCID: 4319391
PMID: 25705179
DOI: 10.3389/fnsys.2015.00004

[…] orm those of single genes (Kuzmin et al., ; Mityaev et al., ; Zabolotneva et al., ,), and tissue from old vs. young patients, illustrating how this method may be useful for the screening of potential geroprotectors (Zhavoronkov and Cantor, ). Other applications include drug discovery and drug repurposing, as well as applications in manipulating cell differentiation.Here, we suggest that these meth […]


The OncoFinder algorithm for minimizing the errors introduced by the high throughput methods of transcriptome analysis

Front Mol Biosci
PMCID: 4428387
PMID: 25988149
DOI: 10.3389/fmolb.2014.00008

[…] le genetics of aging and longevity are complex, the knowledge base is rapidly increasing (Moskalev et al., ), cancer is related to aging (Blagosklonny and Campisi, ) and anti-cancer agents may act as geroprotectors (Blagosklonny, ) and geroprotectors may provide be used in cancer prevention (Blagosklonny, ). The ability of the OncoFinder algorithm to perform the cross-platform comparison of the ge […]


Looking to check out a full list of citations?

Geroprotectors institution(s)
Laboratory of Molecular Radiobiology and Gerontology, Institute of Biology of Komi Science Center of Ural Branch of Russian Academy of Sciences, Syktyvkar, Russia; Moscow Institute of Physics and Technology, Dolgoprudny, Russia; Laboratory of postgenomic studies, Engelhardt Institute of Molecular Biology of Russian Academy of Sciences, Moscow, Russia; School of Systems Biology, George Mason University, Manassas, VA, USA; Integrative Genomics of Ageing Group, Institute of Integrative Biology, University of Liverpool, Liverpool, UK; The Shraga Segal Department of Microbiology, Immunology, and Genetics, Center for Multidisciplinary Research on Aging, Ben-Gurion University of the Negev, Beer Sheva, Israel; Insilico Medicine, Inc., Johns Hopkins University, Baltimore, MD, USA; The Research Institute for Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia; Institute of Physiologically Active Compounds of Russian Academy of Sciences, Chernogolovka, Russia; Xpansa, Conzl OU, Tallinn, Estonia; Infinity Sciences, Inc, Lewes, DE, USA; Genetics, Genomics, and Informatics, University of Tennessee Health Science Center, Memphis, TN, USA; Buck Institute for Research on Aging, Novato, CA, USA; D. Rogachev Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russia; The Biogerontology Research Foundation, London, UK; The Judea Regional R&D Center, Carmel, Israel
Geroprotectors funding source(s)
This work was supported in part by the Wellcome Trust, the Israel Ministry of Science and Technology, and the Fund in Memory of Dr. Amir Abramovich.

Geroprotectors reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review Geroprotectors